Phase 4 study

Recruiting Phase 4

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 4
Sponsor Morten H. Bestle
Registry number NCT04180397
Started 17 August 2020 Today 16 October 2026 Estimated completion 30 April 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Department of Intensive Care, Liverpool Hospital Sydney Australia Recruiting
Department of Intensive Care, Royal North Shore Hospital Sydney Australia Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 1000

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria: ALL below must be met.

* Acute admission to the intensive care unit.

* Age ≥ 18 years of age

* Fluid overload ≥ 5% of ideal body weight. If possible, all fluids administered before admission to the intensive care unit are to be included in the calculation of cumulative fluid balance.

* Clinical stable (minimum criteria: MAP \> 50 mmHg and maximum infusion of 20 microgram/kg/minute of noradrenaline and lactate \< 4.0 mmol/L)

Exclusion Criteria:

* Known allergy to furosemide or sulphonamides.

* Known pre-hospitalization advanced chronic kidney disease (eGFR \< 30 mL/minute/1.73 m\^2 or chronic RRT).

* Ongoing renal replacement therapy.

* Anuria \> 6 hours.

* Rhabdomyolysis with indication for forced diuresis

* Ongoing life-threatening bleeding as these patients need specific fluid/blood product strategies.

* Acute burn injury of more than 10% of the body surface area as these patients need a specific fluid strategy.

* Severe dysnatremia (p-Na \< 120 or \> 155 mmol/L) as these patients need a specific fluid strategy.

* Severe hepatic failure as per the clinical team.

* Patients undergoing forced treatment.

* Fertile women (women \< 50 years) with positive urine human chorionic gonadotropin (hCG) or plasma-hCG.

* Consent not obtainable as per the model approved for the specific trial site.

Dates on the record

Started 17 August 2020
Estimated completion 30 April 2027
Registry last updated 3 June 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 3 June 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.